Publication: Comparative Effectiveness of Natalizumab, Fingolimod, and First-Line Therapies for Rapidly Evolving Severe Relapsing-Remitting Multiple Sclerosis
| dc.authorwosid | Boz, Cavit/V-5127-2017 | |
| dc.authorwosid | Terzi̇, Murat/Aaa-1284-2021 | |
| dc.authorwosid | Horakova, Dana/D-4649-2011 | |
| dc.authorwosid | Jokubaitis, Vilija/Aad-5949-2019 | |
| dc.authorwosid | Van Pesch, Vincent/Aak-9506-2020 | |
| dc.authorwosid | Lugaresi, Alessandra/C-7743-2012 | |
| dc.authorwosid | Pucci, Eugenio/Aaf-8520-2019 | |
| dc.contributor.author | Spelman, T. | |
| dc.contributor.author | Acosta, C. | |
| dc.contributor.author | Hyde, R. | |
| dc.contributor.author | Campbell, N. | |
| dc.contributor.author | Havrdova, E. | |
| dc.contributor.author | Horakova, D. | |
| dc.contributor.author | Butzkueven, H. | |
| dc.date.accessioned | 2025-12-11T00:50:14Z | |
| dc.date.issued | 2020 | |
| dc.department | Ondokuz Mayıs Üniversitesi | en_US |
| dc.department-temp | [Spelman, T.; Jokubaitis, V.] Monash Univ, Melbourne, Vic, Australia; [Acosta, C.; Hyde, R.] Biogen Int, Baar, Switzerland; [Campbell, N.] Biogen, Cambridge, MA USA; [Havrdova, E.; Horakova, D.] Charles Univ Prague, Prague, Czech Republic; [Havrdova, E.; Horakova, D.] Gen Univ Hosp Prague, Prague, Czech Republic; [Trojano, M.] Univ Bari, Bari, Italy; [De Luca, G.] SS Annunziata Hosp, Chieti, Italy; [Lugaresi, A.] Univ Bologna, IRCCS Ist Sci Neurol Bologna, Bologna, Italy; [Lugaresi, A.] Univ Bologna, Dipartimento Sci Biomed & Neuromotorie, Bologna, Italy; [Izquierdo, G.] Hosp Univ Virgen Macarena, Seville, Spain; [Grammond, P.] CISSS Chaudicre Appalache, Levis, PQ, Canada; [Duquette, P.] Hop Notre Dame De Bon Secours, Montreal, PQ, Canada; [Duquette, P.] CHUM, Montreal, PQ, Canada; [Duquette, P.] Univ Montreal, Montreal, PQ, Canada; [Alroughani, R.] Amiri Hosp, Sharq, Kuwait; [Pucci, E.] Azienda Sanit Unica Reg Marchef AV3, UOC Neurol, Macerata, Italy; [Granella, F.] Univ Parma, Parma, Italy; [Lechner-Scott, J.] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW, Australia; [Lechner-Scott, J.] John Hunter Hosp, Hunter New England Health, Dept Neurol, Newcastle, NSW, Australia; [Sola, P.; Ferraro, D.] Azienda Osped Univ, Modena, Italy; [Grand-Maison, F.] Neuro Rive Sud, Greenfield Pk, PQ, Canada; [Terzi, M.] 19 Mayis Univ, Samsun, Turkey; [Rozsa, C.] Jahn Ferenc Teaching Hosp, Budapest, Hungary; [Boz, C.] KTU Med Fac Farabi Hosp, Trabzon, Turkey; [Hupperts, R.] Zuyderland Ziekenhuis, Sittard, Netherlands; [Van der Walt, A.] Monash Univ, Cent Clin Sch, Dept Neurosci, Alfred Hlth,Clin Neurosci, Melbourne, Vic, Australia; [Van Pesch, V.] Clin Univ St Luc, Brussels, Belgium; [Oreja-Guevara, C.] Hosp Clin San Carlos, IdISSC, Madrid, Spain; [Oreja-Guevara, C.] Univ Complutense, Hosp Univ La Paz, Madrid, Spain; [Kalincik, T.] Univ Melbourne, Dept Med, CORe, Melbourne, Vic, Australia; [Kalincik, T.] Royal Melbourne Hosp, Dept Neurol, Melbourne, Vic, Australia; [Butzkueven, H.] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia; [Butzkueven, H.] Alfred Hosp, Dept Neurol, Melbourne, Vic, Australia; [Butzkueven, H.] Monash Univ, Box Hill Hosp, Dept Neurol, Melbourne, Vic, Australia | en_US |
| dc.description.woscitationindex | Science Citation Index Expanded - Conference Proceedings Citation Index - Science | |
| dc.identifier.endpage | 527 | en_US |
| dc.identifier.issn | 1352-4585 | |
| dc.identifier.issn | 1477-0970 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | 526 | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/39610 | |
| dc.identifier.volume | 26 | en_US |
| dc.identifier.wos | WOS:000596547101625 | |
| dc.identifier.wosquality | Q1 | |
| dc.language.iso | en | en_US |
| dc.publisher | Sage Publications Ltd | en_US |
| dc.relation.ispartof | Multiple Sclerosis Journal | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Comparative Effectiveness of Natalizumab, Fingolimod, and First-Line Therapies for Rapidly Evolving Severe Relapsing-Remitting Multiple Sclerosis | en_US |
| dc.type | Conference Object | en_US |
| dspace.entity.type | Publication |
